SEARCH

SEARCH BY CITATION

Keywords:

  • γ-secretase;
  • presenilin;
  • Notch;
  • VEGFR-1;
  • angiogenesis;
  • receptor translocation;
  • amyloid
  • • 
    Introduction
  • • 
    Regulated intramembrane proteolysis
  • • 
    γ-Secretase
    • – 
      Structure
    • – 
      Receptor cleavage
  • • 
    Is there more to γ-Secretase than regulated intramembrane proteolysis?
    • – 
      Receptor translocation
    • – 
      Presenilin-binding proteins
    • – 
      Phosphorylation
  • • 
    Role of γ-Secretase in angiogenesis
    • – 
      Notch
    • – 
      Vascular endothelial growth factor receptor-1 (VEGFR-1)
    • – 
      Insulin-like growth factor-I receptor (IGF-1R)
    • – 
      ErbB4
    • – 
      Cadherins
    • – 
      Amyloid precursor protein (APP)
    • – 
      Other substrates
  • • 
    γ-Secretase as a therapeutic target
  • • 
    γ-Secretase, what next?

Abstract

Physiological angiogenesis is essential for development, homeostasis and tissue repair but pathological neovascularization is a major feature of tumours, rheumatoid arthritis and ocular complications. Studies over the last decade have identified γ-secretase, a presenilin-dependent protease, as a key regulator of angiogenesis through: (i) regulated intramembrane proteolysis and transmembrane cleavage of receptors (e.g. VEGFR-1, Notch, ErbB-4, IGFI-R) followed by translocation of the intracellular domain to the nucleus, (ii) translocation of full length membrane-bound receptors to the nucleus (VEGFR-1), (iii) phosphorylation of membrane bound proteins (VEGFR-1 and ErbB-4), (iv) modulation of adherens junctions (cadherin) and regulation of permeability and (v) cleavage of amyloid precursor protein to amyloid-β which is able to regulate the angiogenic process. The γ-secretase-induced translocation of receptors to the nucleus provides an alternative intracellular signalling pathway, which acts as a potent regulator of transcription. γ-secretase is a complex composed of four different integral proteins (presenilin, nicastrin, Aph-1 and Pen-2), which determine the stability, substrate binding, substrate specificity and proteolytic activity of γ-secretase. This seeming complexity allows numerous possibilities for the development of targeted γ-secretase agonists/antagonists, which can specifically regulate the angiogenic process. This review will consider the structure and function of γ-secretase, the growing evidence for its role in angiogenesis and the substrates involved, γ-secretase as a therapeutic target and future challenges in this area.